XML 28 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (65,101) $ (18,367)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 2,463 1,789
Loss on sale and impairment of long-lived assets 68 167
Loss (gain) on extinguishment of debt   247
Loss on remeasurement of debt   454
Loss on remeasurement of warrants 15,910 1,079
Loss (gain) on remeasurement of contingent consideration (355) (80)
Loss on remeasurement of earnout liability 18,770  
Stock-based compensation 16,835 672
Interest expense (non-cash) 311 1,089
Other (225)  
Change in operating assets and liabilities, net of acquisitions and divestitures    
Accounts receivable (846) 559
Prepaid expenses and other current assets 441 281
Long-term insurance commissions receivable (1,383) (174)
Accounts payable (8,090) 1,414
Accrued expenses and other current liabilities 2,625 1,651
Deferred revenue (1,362) 136
Refundable customer deposits (837) (880)
Contingent consideration - business combination (1,663)  
Other (496) 158
Net cash used in operating activities (22,935) (9,638)
Cash flows from investing activities:    
Purchases of property and equipment (34) (84)
Capitalized internal use software development costs (798) (890)
Acquisitions, net of cash acquired (22,882)  
Net cash used in investing activities (23,714) (974)
Cash flows from financing activities:    
Proceeds from debt issuance, net of fees   1,940
Repayments of principal and related fees (150) (401)
Proceeds from issuance of redeemable convertible preferred stock, net of fees   4,714
Proceeds from exercises of warrants 89,771  
Proceeds from exercises of stock options 355 1
Income tax withholdings paid upon vesting of restricted stock units (16,997)  
Settlement of contingent consideration related to a business combination (400)  
Net cash provided by financing activities 72,579 6,254
Change in cash, cash equivalents, and restricted cash 25,930 (4,358)
Cash, cash equivalents, and restricted cash, beginning of period 207,453 7,179
Cash, cash equivalents, and restricted cash end of period 233,383 2,821
Supplemental disclosures    
Conversion of debt to redeemable convertible preferred stock (non-cash)   1,436
Cash paid for interest 903 1,770
Proceeds receivable from exercises of warrants 3,237  
Reduction of earnout liability due to a vesting event 25,815  
Non-cash consideration for acquisitions 2,906  
As Filed    
Adjustments to reconcile net loss to net cash used in operating activities    
Other   167
Cash flows from financing activities:    
Cash, cash equivalents, and restricted cash, beginning of period $ 207,453 $ 7,179